Back

Effects of luseogliflozin on sympathetic nerve activity:a dual assessment using iodine-123-metaiodobenzylguanidine and muscle sympathetic nerve activity

31 August 2026 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Cardiometabolic pharmacotherapy and cardiovascular outcomes Antidiabetic Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Tadayuki Hirai

Kanazawa University, Kanazawa (Japan)

5 More presentations in this session

Presentation thumbnail
B-type natriuretic peptide level reduction and its predictors following sodium-glucose cotransporter 2 inhibitor treatment in patients with diabetic kidney disease
Doctor T. Nagahiro (Yokohama, JP)
Abstract
Presentation thumbnail
Cardiovascular and renal outcomes of Semaglutide in patients with Type 2 Diabetes Mellitus with established Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease: A Meta-Analysis
Doctor F. Lumancas (Cebu City, PH)
Abstract
Presentation thumbnail
Impact of semaglutide on mortality, cardiovascular, and kidney outcomes across the cardio-kidney-metabolic continuum: a meta-analysis of randomized controlled trials
Doctor C. Cotticelli (Naples, IT)
Abstract
Presentation thumbnail
Comparative cardiovascular efficacy of individual GLP-1 receptor agonists and tirzepatide: a Bayesian network meta-analysis of 13 cardiovascular outcome trials
Ms Y. Srivastava (IN)
Abstract
Presentation thumbnail
Regression of microalbuminuria predicts cardiovascular risk reduction with GLP-1 receptor agonist therapy
Doctor I. Figueroa Baez (San Juan, PR)
Abstract

Access the full session

Session thumbnail
Cardiometabolic pharmacotherapy and cardiovascular outcomes

The Event

Event poster

ESC Congress 2026

31 August 2026 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Sympathetic nervous system hyperactivity induces cardiac dysfunction and remodeling in mice: role of the NADPH oxidase/SGLT 1 and 2 pathways
29 June 2021
thumbnail
Congress Presentation
Empaglifozin modifies the arterial stiffness in type-2 diabetic patients: a preliminary report
13 May 2024
thumbnail
Congress Presentation
The relationship between lung MIBG uptake and clinical response to renal denervation
30 August 2024
thumbnail
Congress Presentation
Sympathetic nerve activity changes following acute exposures to electronic and tobacco cigarette smoking in humans
27 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources